VBI Vaccines - 14 Year Dividend History | VBIV

Historical dividend payout and yield for VBI Vaccines (VBIV) since 2005. The current TTM dividend payout for VBI Vaccines (VBIV) as of June 21, 2019 is $0.00. The current dividend yield for VBI Vaccines as of June 21, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.099B $0.003B
VBI Vaccines Inc. is a biopharmaceutical company developing novel technologies to expand vaccine protection. The company's eVLP vaccine platform allows for the design of enveloped virus-like particle vaccines which closely mimic the target virus. Its lead eVLP asset is a prophylactic cytomegalovirus vaccine. Its second platform is a thermostable technology that enables the development of vaccines and biologics. VBI Vaccines Inc., formerly known as SciVac Therapeutics, Inc., is headquartered in Cambridge, MA.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $114.125B 12.90
Gilead Sciences (GILD) United States $88.452B 10.74
Bio-Techne Corp (TECH) United States $7.965B 54.34